Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

Kurnool: With a spike in hepatitis B and hepatitis C virus cases, the Clinical Microbiology wing at Nandyal Government ...

Liver diseases are rising globally, claiming over 2 million lives annually, with viral hepatitis and alcoholic liver disease ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Hepatitis viruses A to E differ in transmission and severity, ranging from foodborne infections to bloodborne risks. We got in touch with an expert who explains how poor sanitation, contaminated food, ...

Dicerna Pharma has enticed another big pharma to partner its RNA interference platform, attracting a $200 million upfront deal with Roche for a drug to treat hepatitis B virus infections.

Hepatitis B affects almost 300 million people worldwide, according to GSK, and while nucleoside/nucleotide analogue (NA) drugs to treat it are available – such as Gilead’s polymerase inhibitor ...

Robert F. Kennedy Jr. and I rarely see eye to eye, but I’ll grudgingly admit he’s not entirely wrong about food dyes, though ...

A three-drug combination worked better than any of them alone in treating ALS caused by mutations in the SOD1 gene, per a new ...

Trauma Services reports that fentanyl has turned into a crisis for first responders, property managers, and maintenance ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment ...